Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Omega-3 fatty acid in children with Autism Spectrum Disorder
NCT06125782Phase 2Completed
- Sponsor
- Bangabandhu Sheikh Mujib Medical University
- Start
- Sep 2023
- Primary completion
- Jan 2024
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial (2 arms), sponsored by Bangabandhu Sheikh Mujib Medical University. Primary endpoint: Aberrant Behavior Checklist Score at 8 weeks. Started Sep 2023; status: completed.
Beyond the preview
Go deeper on NCT06125782.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06125782.